ISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS), Cerebral Infarction

MANUFACTURER: Daiichi Sankyo Company Limited

USAGE: Intravenous

MEDICINE APPROVED BY:

Pharmaceuticals and Medical Devices Agency (PMDA)

Edaravone, marketed by Daiichi Sankyo under the brand name Radicava, is a medication used in the treatment of amyotrophic lateral sclerosis (ALS). ALS, also known as Lou Gehrig’s disease, is a progressive and debilitating neurodegenerative disorder that affects the motor neurons in the brain and spinal cord, leading to muscle weakness, loss of motor function, and ultimately paralysis.